Based on GEO and TCGA datasets, Zhong et al. found that IGF2BP1 was an independent prognostic factor of breast cancer, and higher expression level of IGF2BP1 was associated with shorter overall survival of breast cancer patients 59, which was consistent with our results. Here, IGF2BP1 is linked to breast carcinoma.